LONDON-- (BUSINESS WIRE)--The global human respiratory syncytial virus drugs market is expected to grow at a CAGR of more than 4% during the forecast period, according to Technavio’s latest report.

Human metapneumovirus is a common respiratory virus discovered in 2001 that causes an upper, and sometimes lower, respiratory infection, according to the World Health Organization website.

A common respiratory viral infection that causes mild, cold-like symptoms is the respiratory syncytial virus (RSV), also known as the human respiratory syncytial virus (hRSV).

A highly anticipated new shot that can protect newborns from the ravages of respiratory syncytial virus may not be available to some families this season because of uncertainties about insurance ...

WHAT WE FOUND Human Metapneumovirus (HMPV) is not new. The respiratory virus was first identified in 2001, according to the Centers for Disease Control and Prevention.

A novel respiratory syncytial virus strain led to infections in all but one of 20 healthy adults in a controlled human infection trial designed to evaluate the safety and infectious potential of ...

A novel vaccine protected cattle from respiratory syncytial virus (RSV) infection. The version of RSV that naturally infects cattle is closely related to human RSV, so the results suggest that a ...

Health officials reported that cases of human metapneumovirus (HMPV) spiked this spring as COVID-19 and Respiratory Syncytial Virus cases fell. National data from the Centers for Disease Control ...

Researchers from VIB, UGent, the Geisel School of Medicine at Dartmouth and several collaborators developed a new antiviral strategy to fight human respiratory syncytial virus (RSV), a leading ...

Lambs make a good model for studying the illness in humans for a few reasons, he said. Lambs are roughly the same size as human infants, and the virus replicates well in their respiratory systems. The ...

Across the United States, cases of respiratory syncytial virus, or RSV, and influenza are increasing. At the same time, Covid-19 cases, which had been dropping, appear to have plateaued over the ...

ORAL PRESENTATION October 1, 2022, 09:45 – 10:00 BST “EDP-323, a Novel L-Protein Inhibitor for the Treatment of Respiratory Syncytial Virus,” Michael Rhodin, Ph.D., United States ...